Literature DB >> 30188873

In pursuit of control and elimination: update on hepatitis A and B epidemiology and prevention strategies.

Victoria Chi1, Shannon Cleary1, Joseph A Bocchini2.   

Abstract

PURPOSE OF REVIEW: This review describes the impact of recommendations for routine immunization of infants and children against hepatitis A and hepatitis B, the changing epidemiology of these infections, and the remaining challenges to controlling or eliminating these diseases in the United States. RECENT
FINDINGS: Rates of hepatitis A and B have significantly declined because of childhood vaccination programs and long-term protection provided by infant immunization. However, hepatitis A immunization rates remain lower than other vaccines, and outbreaks continue to occur in part due to a growing number of susceptible adults. The Advisory Committee on Immunization Practice has updated pre and postexposure prophylaxis and travel recommendations for hepatitis A prevention in young infants, as well as recommendations to reduce ongoing perinatal transmission of hepatitis B.
SUMMARY: Pediatric healthcare providers should continue to immunize all infants against hepatitis A and B and ensure that no child outgrows the pediatric practice without being vaccinated. To address hepatitis A, providers should be aware of new recommendations for unimmunized travelers, use vaccines to prevent and control outbreaks, and ensure postexposure prophylaxis. Universal vaccination of infants against hepatitis B should begin before hospital discharge. The prevention of perinatal transmission is critical for control and possible eradication of hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30188873     DOI: 10.1097/MOP.0000000000000672

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  2 in total

1.  Is hepatitis A virus infection under control? lessons in the application of viral sequencing for the development of vaccination schemes in emergency situations.

Authors:  Nora A Fierro
Journal:  EBioMedicine       Date:  2018-12-11       Impact factor: 8.143

2.  Seroprevalence and incidence of hepatitis A in Southeast Asia: A systematic review.

Authors:  Gustavo Hernandez-Suarez; Debasish Saha; Kris Lodroño; Phatu Boonmahittisut; Stephanus Taniwijaya; Ashwini Saha; Selim Badur; Yong Poovorawan
Journal:  PLoS One       Date:  2021-12-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.